Cargando…

Treatment of immobilization-related hypercalcaemia with denosumab

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Malberti, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094408/ https://www.ncbi.nlm.nih.gov/pubmed/27818771 http://dx.doi.org/10.1093/ckj/sft013

Ejemplares similares

Treatment of immobilization-related hypercalcaemia with denosumab
por: Malberti, Fabio
Publicado: (2012)

Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure
por: de Beus, Esther, et al.
Publicado: (2012)

Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
por: Sydlik, Carmen, et al.
Publicado: (2020)

The Efficacy of Denosumab in the Management of a Tibial Paediatric Aneurysmal Bone Cyst Compromised by Rebound Hypercalcaemia
por: Harcus, Matthew, et al.
Publicado: (2020)

Treatment of malignant hypercalcaemia with clodronate.
por: Percival, R. C., et al.
Publicado: (1985)

Treatment of extreme hypercalcaemia: the role of haemodialysis
por: Basok, Anna B., et al.
Publicado: (2018)

Clues from hypercalcaemia
por: Nicholson, S, et al.
Publicado: (2002)

Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).
por: O'Rourke, N. P., et al.
Publicado: (1994)

Hypercalcaemia Mimicking STEMI on Electrocardiography
por: Donovan, Joseph, et al.
Publicado: (2010)

Hypercalcaemia and hypocalcaemia: finding the balance
por: Body, Jean-Jacques, et al.
Publicado: (2017)

EP20 Hypercalcaemia in sarcoidosis
por: Chopra, Tanya, et al.
Publicado: (2020)

Vitamin D toxicity and hypercalcaemia
por: Singh, Pooja, et al.
Publicado: (2021)

A clinical perspective of parathyroid hormone related hypercalcaemia
por: Han, Chau H., et al.
Publicado: (2019)

Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
por: Nizar, Ryizan, et al.
Publicado: (2021)

Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis
por: Taylor-Miller, Tashunka, et al.
Publicado: (2020)

Immobilization of Denosumab on Titanium Affects Osteoclastogenesis of Human Peripheral Blood Monocytes
por: Beck, Felicitas, et al.
Publicado: (2019)

Hypercalcaemia--new mechanisms for old observations.
por: Waxman, J.
Publicado: (1990)

Paraneoplastic Hypercalcaemia Associated with TCC of Bladder
por: Patel, A. B., et al.
Publicado: (2004)

Electrographic Osborn wave in severe hypercalcaemia
por: Asbeutah, Abdul Aziz A, et al.
Publicado: (2019)

An unexpected case of hypercalcaemia and hilar fullness
por: Laher, M, et al.
Publicado: (2020)

Genetic causes of neonatal and infantile hypercalcaemia
por: Gorvin, Caroline M.
Publicado: (2021)

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
por: Ralston, S. H., et al.
Publicado: (1997)

Recombinant PTH associated with hypercalcaemia and renal failure
por: Ayasreh, Nadia, et al.
Publicado: (2013)

Hypercalcaemia with Hypocalcuria, an Unusual Case of Primary Hyperparathyroidism
por: Forbes, H. A. W., et al.
Publicado: (1956)

Complexities surrounding the diagnosis and management of hypercalcaemia in pregnancy
por: Rodrigo, Natassia, et al.
Publicado: (2021)

Cutaneous xanthoma causing hypercalcaemia in a cat
por: Ma, Doris, et al.
Publicado: (2022)

An uncanny case of paraneoplastic calcitriol mediated hypercalcaemia
por: Shah, Preet Mukesh, et al.
Publicado: (2023)

Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
por: Shah, S, et al.
Publicado: (2002)

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
por: O'Rourke, N. P., et al.
Publicado: (1993)

Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017)

Hypercalcaemia secondary to hypophysitis and cortisol deficiency: another immunotherapy-related adverse event
por: Miller, Samuel R, et al.
Publicado: (2022)

Alpha-2 HS glycoprotein in the hypercalcaemia of multiple myeloma.
por: Crawford, S. M.
Publicado: (1984)

Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia
por: Lee, Angela S, et al.
Publicado: (2015)

Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary?
por: Lunn, Mitchell R., et al.
Publicado: (2010)

Severe Hypercalcaemia – Chronic Tophaceous Gout as the Responsible Cause?
por: Rodríguez-Gutiérrez, René, et al.
Publicado: (2015)

The Neurological Aspects of Hypercalcaemia: With Special Reference to Primary Hyperparathyroidism
por: Henson, R. A.
Publicado: (1966)

Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder
por: Ravindran, Ravikumar, et al.
Publicado: (2020)

Case Report: Familial Hypocalciuric Hypercalcaemia and Hashimoto's Thyroiditis
por: Mobarak, Shahd, et al.
Publicado: (2020)

hypercalcaemia due to a calcitriol-producing neuroendocrine tumour
por: van Lierop, Antoon H, et al.
Publicado: (2019)

Vitamin D toxicity presenting with altered sensorium and hypercalcaemia
por: Sarma, Anuj
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uveo1uls7q2uuv35nrbn5spfhd